2022
DOI: 10.1016/j.bsheal.2022.03.004
|View full text |Cite
|
Sign up to set email alerts
|

Combination of chemistry and material science to overcome health problems

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(8 citation statements)
references
References 12 publications
0
8
0
Order By: Relevance
“…Nanomaterials can encapsulate promising drug candidates and allow effective cellular uptake and accumulation at target sites to overcome the limitations of medicinal chemistry. [ 23 ] In addition, for nanomaterials, the surface charge also affects the pharmacokinetic properties. [ 24 ] Therefore, we examined the distribution of CuET‐Lipid@Cela resulting from the increased zeta potential after the addition of CuET into the Lipid materials.…”
Section: Resultsmentioning
confidence: 99%
“…Nanomaterials can encapsulate promising drug candidates and allow effective cellular uptake and accumulation at target sites to overcome the limitations of medicinal chemistry. [ 23 ] In addition, for nanomaterials, the surface charge also affects the pharmacokinetic properties. [ 24 ] Therefore, we examined the distribution of CuET‐Lipid@Cela resulting from the increased zeta potential after the addition of CuET into the Lipid materials.…”
Section: Resultsmentioning
confidence: 99%
“…Recently, a novel concept of biosafety materials has been proposed, 8,9 which advocates the development of innovative materials for the antibacterial field. 10,11 Several antibacterial materials have been successfully synthesized and even applied in clinical settings, 12 including but not limited to natural, inorganic, and organic antibacterial materials. [13][14][15] These materials are easily obtainable and possess commendable bactericidal capabilities, owing to continuous improvements.…”
Section: Introductionmentioning
confidence: 99%
“…Biosafety is a crucial consideration for in vivo administration. , To assess the biosafety, NPt IV @siXkr8 and other control Pt-containing formulations were intravenously administered three times at a dose of 3.5 mg/kg body weight and an interval of 3 days to balb/c mice. Blood physiological and biochemical parameters were then evaluated 10 days after first administration to ensure biosafety.…”
Section: Introductionmentioning
confidence: 99%